Gitnux/Report 2026

Contract Manufacturing Industry Statistics

The global contract manufacturing market is projected at $804 billion in 2026, explore the figures behind growth, companies and trends across contract manufacturing.
20Statistics
36Sources
4Sections
1Visuals
15mRead
Contract Manufacturing Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The contract manufacturing industry at a glance

Global contract manufacturing is projected at $804 billion in 2026, with growth supported by outsourcing, automation, supply-chain diversification and rising demand for specialized pharmaceutical and electronics production.

$804B[10]
Global market, 2026 estimate
8.7%[10]
Forecast CAGR, 2025–2030
$173.7B
Pharmaceutical CDMO market, 2025
30%
Top five pharma CDMO share, 2025
Market size
The global contract manufacturing market was estimated at $804 billion in 2026 in a 2025 sector outlook. A separate market study estimated the market at $724.35 billion in 2025, reflecting differences in scope and methodology across reports.[10][4]
Forecast & CAGR
The sector outlook projects growth from $740 billion in 2025 to $1.123 trillion in 2030, equivalent to an 8.7% CAGR. Mordor Intelligence forecasts a lower 5.98% CAGR from 2025 to 2030, reaching $966.84 billion.[10][4]
Market share & regions
Asia Pacific is identified as the largest regional contract manufacturing market, while the Middle East is forecast to be the fastest-growing region. In pharmaceutical CDMO, North America is the largest market and accounted for 41.2% in 2025, according to one recent industry estimate.[4][11]
Segmentation
Contract manufacturing spans electronics manufacturing services, pharmaceutical and biologics CDMO, medical devices, consumer products, automotive, industrial equipment and other specialized production. In pharmaceutical CDMO, contract development represented 23.1% of 2025 revenue, covering formulation, process development, analytical methods and clinical manufacturing.[12]
Key players & concentration
The pharmaceutical CDMO market remains moderately concentrated: Lonza held more than 12% of 2025 revenue, while Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics and WuXi Biologics together held 30%. The broader contract manufacturing market is described as having medium concentration.[4]
Pricing
Public industry sources reviewed did not provide a reliable, standardized global price index for contract manufacturing services. Pricing varies by service type, production scale, technology, regulatory requirements, capacity reservation and contract structure; strategic partnerships accounted for 60.54% of the market by contract type in 2024.[4]
Trends, drivers & challenges
Growth is being driven by OEM outsourcing, automation, digital transformation, reshoring and supply-chain diversification. The electronics manufacturing services market was estimated at approximately $640–650 billion in 2025 and is being shaped by product complexity, AI-related demand and the expansion of end-to-end design, testing and logistics services; key challenges include labor shortages, capital intensity and geopolitical supply-chain risk.[12][10]
Consumer behavior & competition
End customers increasingly expect shorter commercialization timelines, reliable availability, regulatory compliance and products tailored to specialized applications. In electronics, demand for AI-enabled products is increasing competition for advanced manufacturing capacity, while in consumer products retailers are seeking greater product differentiation, stronger delivery performance and more private-label production.[12][13]
M&A
M&A activity in pharmaceutical contract manufacturing remains active. In November 2026, Lonza agreed to acquire five U.S. CDMO manufacturing sites from Merck KGaA, expanding its U.S. footprint from four to nine sites; in January 2026, Siegfried agreed to acquire drug-substance businesses and sites in the United States and Australia.[14][15]
Regulation
U.S. FDA guidance requires contract manufacturing arrangements for drugs to define each party’s manufacturing responsibilities and compliance with current good manufacturing practice. FDA guidance for active pharmaceutical ingredients also calls for written agreements specifying GMP responsibilities and quality measures.[16]
Latest news
The most recent major transaction identified was Lonza’s November 3, 2026 agreement to acquire five U.S. CDMO sites from Merck KGaA. Lonza said the transaction would add end-to-end development and manufacturing capabilities and strengthen its presence in the U.S., the largest market for innovative pharmaceuticals.[14][17]

02 Ranking

Top 10 Companies in the Contract Manufacturing Industry

The leading companies in the contract manufacturing industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Taiwan Semiconductor Manufacturing Company stands out for semiconductor foundry manufacturing because it manufactured products for 534 customers in 2025, while Samsung Biologics focuses on biologics CDMO leads in CDMO revenue since it reported FY2025 revenue of KRW4.557 trillion from its CDMO business.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in semiconductor foundry

    Taiwan Semiconductor Manufacturing Company

    TW

    Ranked #1 · 9.3 · Semiconductor foundry

    Why we picked it: It runs a dedicated foundry model and served 534 customers in 2025, alongside an an operating margin of 50.8%.

  2. Leader in biologics CDMO

    Samsung Biologics

    KR

    Ranked #2 · 9.2 · Biologics CDMO

    Why we picked it: It reported KRW4.557 trillion in FY2025 CDMO business revenue with an operating margin of 45.4%.

  3. Leader in optical & electronics OEM

    Fabrinet

    KY

    Ranked #3 · 9.1 · Optical & electronics OEM

    Why we picked it: Its contract manufacturing focus targets complex OEM products across optical, precision, and electronics.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the contract manufacturing industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Taiwan Semiconductor Manufacturing Company

Semiconductor foundry · TW

9.3
2

Samsung Biologics

Biologics CDMO · KR

9.2
3

Fabrinet

Optical & electronics OEM · KY

9.1
4

Celestica

Advanced electronics manufacturing and supply-chain services · CA

9.0
5

Luxshare Precision Industry

Consumer electronics manufacturing · CN

9.0
6

WuXi AppTec

Pharmaceutical CRDMO services worldwide · CN

9.0
7

Wistron

Computing, cloud and communications manufacturing · TW

8.6
8

Sanmina

Industrial, medical, defense and communications manufacturing · US

8.6
9

Siegfried

Pharmaceutical API and finished-dose CDMO · CH

8.3
10

Pegatron

Computing, communications and consumer electronics manufacturing · TW

8.0

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the contract manufacturing industry. In Contract Manufacturing Industry Statistics. Gitnux. https://gitnux.org/contract-manufacturing-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest contract manufacturing companies

Celestica leads with $12.4B in annual revenue (group level, converted to USD).

Celestica$12.4B
Sanmina$8.1B
Fabrinet$3.4B
Samsung Biologics$3.3B
Siegfried$1.5B
source-verifiedcorporate.celestica.com · ir.sanmina.com · investor.fabrinet.com · samsungbiologics.com · siegfried.ch2025

04 Statistics

Technology

In 2026, AI moves beyond pilots for 40% of surveyed contract development and manufacturing organizations, while 27% report integrated electronic batch records.

AI in production and inspection in the contract manufacturing industry

  • 40% of surveyed global contract development and manufacturing organizations deploy artificial intelligence beyond the pilot stage in 2026, up from 23% in 2025.[1]
  • 60% of surveyed CDMO and CMO validation professionals do not actively use artificial intelligence in validation.[2]
  • 62% of surveyed global CDMOs expect artificial intelligence to deliver significant operational value within two years.[1]

Digital operations in the contract manufacturing industry

  • 27% of surveyed global CDMOs have integrated electronic batch records.[1]
  • 25% of surveyed global contract development and manufacturing organizations use manufacturing execution systems.[1]
  • 57% of surveyed global CDMOs rate themselves as Connected, Integrated or Intelligent on the digital-maturity scale.[1]

05 Statistics

Market Intelligence

Market estimates differ by scope: the 2025 global contract manufacturing market is estimated at $686.4 billion and $724.35 billion, with 2030 forecasts of $968.7 billion and $966.84 billion.

Market size, volume and shipments in the contract manufacturing industry

  • USD 686.4 billion was the estimated 2025 global contract manufacturing market, covering outsourced production and manufacturing services; BCC Research reports market revenue.[3]
  • USD 724.35 billion was the estimated 2025 global contract manufacturing market, covering outsourced manufacturing services across product sectors; Mordor Intelligence uses market revenue as the measure.[4]
  • USD 243.03 billion was the estimated 2025 global contract manufacturing market, using Fortune Business Insights’ market definition and revenue measure.[5]

Forecast growth and shipments in the contract manufacturing industry

  • The global contract manufacturing market was forecast to grow from USD 686.4 billion in 2025 to USD 968.7 billion in 2030, a 7.1% CAGR.[3]
  • The global contract manufacturing market was forecast to grow from USD 724.35 billion in 2025 to USD 966.84 billion in 2030, a 5.98% CAGR.[4]
  • The United States contract manufacturing services market was forecast to increase from USD 248.11 billion in 2025 to USD 374.82 billion in 2031, a 7.12% CAGR.[4]

06 Statistics

Strategy & Growth

U.S. electronic contract manufacturing services M&A shows continued deal activity, with 15 transactions in the first half of 2024 and $445 million reported value.

M&A and consolidation in the contract manufacturing industry

  • 15 M&A transactions occurred in U.S. electronic contract manufacturing services during the first half of 2024, up 15% from 13 in the first half of 2023.[6]
  • 72% of 156 U.S. contract-manufacturer acquisitions announced from 2019 through October 2026 had financial buyers, including private-equity platforms, add-ons, recapitalizations and take-privates.[7]
  • 21 acquisitions of U.S. contract manufacturers were announced in 2025, down from 25 in 2024, in a catalog covering food, beverage, supplements, personal care and related co-manufacturers.[7]
  • 58.8% of full-year 2025 medical-device outsourced-manufacturing M&A activity was in the Contract Manufacturing segment, compared with 50.8% year-to-date in 2026.[8]
  • $445 million was the reported M&A transaction value for U.S. electronic contract manufacturing services in the first half of 2024, up 6% from $421 million in the first half of 2023.[6]

07 Statistics

Pricing & Finance

Electronics manufacturing services returns stay low in public studies, with 2024 return on assets of 4.0% and 2024 return on sales of 2.5% for 41 large firms.

Margins and profitability in the contract manufacturing industry

  • 4.0% was the 2024 return on assets for 41 large global electronics manufacturing services contract manufacturers in New Venture Research’s 2025 industry study.[9]
  • 2.5% was the 2024 return on sales for 41 large global electronics manufacturing services contract manufacturers in New Venture Research’s 2025 industry study.[9]
  • 7.5% was the 2024 gross margin for 41 large global electronics manufacturing services contract manufacturers in New Venture Research’s 2025 industry study.[9]

Key questions about the contract manufacturing industry

What is the global contract manufacturing market size for 2026?
The global contract manufacturing market is projected at $804 billion in 2026.
How fast is the global contract manufacturing market expected to grow?
The sector outlook projects growth from $740 billion in 2025 to $1.123 trillion in 2030, an 8.7% CAGR. Mordor Intelligence forecasts a lower 5.98% CAGR from 2025 to 2030, reaching $966.84 billion.
Which companies lead the contract manufacturing industry?
Taiwan Semiconductor Manufacturing Company stands out for semiconductor foundry manufacturing because it manufactured products for 534 customers in 2025, while Samsung Biologics focuses on biologics CDMO leads in CDMO revenue since it reported FY2025 revenue of KRW4.557 trillion from its CDMO business.
What technology shifts are showing up in contract development and manufacturing?
In 2026, 40% of surveyed organizations deploy artificial intelligence beyond the pilot stage, up from 23% in 2025. In the same survey, 27% have integrated electronic batch records and 25% use manufacturing execution systems.
How concentrated is the pharmaceutical CDMO market?
The pharmaceutical CDMO market is moderately concentrated, with Lonza holding more than 12% of 2025 revenue. Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics and WuXi Biologics together held 30%.
What do FDA contract manufacturing arrangements require for drug and API work?
U.S. FDA guidance requires arrangements to define each party’s manufacturing responsibilities and compliance with current good manufacturing practice. Guidance for active pharmaceutical ingredients also calls for written agreements specifying GMP responsibilities and quality measures.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Contract Manufacturing Industry Statistics. Gitnux. https://gitnux.org/contract-manufacturing-industry-statistics
MLA
Samuel Norberg. "Contract Manufacturing Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/contract-manufacturing-industry-statistics.
Chicago
Samuel Norberg. 2026. "Contract Manufacturing Industry Statistics." Gitnux. https://gitnux.org/contract-manufacturing-industry-statistics.